Sargent Bickham Lagudis’s Exact Sciences EXAS Stock Holding History

Sargent Bickham Lagudis’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$11.6K	Hold	235	–	–	﹤0.01%	706
2022 Q3	$7K	Hold	235	–	–	﹤0.01%	742
2022 Q2	$10K	Hold	235	–	–	﹤0.01%	692
2022 Q1	$17K	Hold	235	–	–	﹤0.01%	632
2021 Q4	$18K	Hold	235	–	–	﹤0.01%	615
2021 Q3	$22K	Hold	235	–	–	﹤0.01%	587
2021 Q2	$29K	Sell	235 -84	-26%	-$10K	﹤0.01%	550
2021 Q1	$42K	Sell	319 -1,116	-78%	-$153K	﹤0.01%	464
2020 Q4	$190K	Buy	1,435 +1,038	+261%	+$126K	0.02%	247
2020 Q3	$40K	Hold	397	–	–	﹤0.01%	415
2020 Q2	$35K	Hold	397	–	–	﹤0.01%	410
2020 Q1	$23K	Buy	397 +292	+278%	+$23.7K	﹤0.01%	442
2019 Q4	$10K	Hold	105	–	–	﹤0.01%	610
2019 Q3	$9K	Hold	105	–	–	﹤0.01%	576
2019 Q2	$12K	Hold	105	–	–	﹤0.01%	562
2019 Q1	$9K	Buy	+105	New	+$8.94K	﹤0.01%	627

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sargent Bickham Lagudis's EXAS Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Exact Sciences (EXAS) position steady in Q4 2022 at 235 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Sargent Bickham Lagudis first reported a position in EXAS in Q1 2019 and has held it in 16 quarters since. The position peaked at $190K in Q4 2020. 550 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

Sargent Bickham Lagudis held 235 shares of Exact Sciences worth $11.6K as of Q4 2022.
Sargent Bickham Lagudis left its Exact Sciences share count unchanged in Q4 2022.
Exact Sciences made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #706 holding.
Sargent Bickham Lagudis first reported a position in Exact Sciences in Q1 2019 and has held it in 16 quarters since.
Sargent Bickham Lagudis's Exact Sciences position peaked at $190K in Q4 2020.
550 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.